• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盆腔放射性疾病的预防

Prevention of pelvic radiation disease.

作者信息

Fuccio Lorenzo, Frazzoni Leonardo, Guido Alessandra

机构信息

Lorenzo Fuccio, Leonardo Frazzoni, Department of Medical and Surgical Sciences, S.Orsola-Malpighi Hospital, University of Bologna, 40136 Bologna, Italy.

出版信息

World J Gastrointest Pharmacol Ther. 2015 Feb 6;6(1):1-9. doi: 10.4292/wjgpt.v6.i1.1.

DOI:10.4292/wjgpt.v6.i1.1
PMID:25664197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4318744/
Abstract

Pelvic cancers are among the most frequently diagnosed cancers worldwide. Treatment of patients requires a multidisciplinary approach that frequently includes radiotherapy. Gastrointestinal (GI) radiation-induced toxicity is a major complication and the transient or long-term problems, ranging from mild to very severe, arising in non-cancerous tissues resulting from radiation treatment to a tumor of pelvic origin, are actually called as pelvic radiation disease. The incidence of pelvic radiation disease changes according to the radiation technique, the length of follow up, the assessment method, the type and stage of cancer and several other variables. Notably, even with the most recent radiation techniques, i.e., intensity-modulated radiotherapy, the incidence of radiation-induced GI side effects is overall reduced but still not negligible. In addition, radiation-induced GI side effects can develop even after several decades; therefore, the improvement of patient life expectancy will unavoidably increase the risk of developing radiation-induced complications. Once developed, the management of pelvic radiation disease may be challenging. Therefore, the prevention of radiation-induced toxicity represents a reasonable way to avoid a dramatic drop of the quality of life of these patients. In the current manuscript we provide an updated and practical review on the best available evidences in the field of the prevention of pelvic radiation disease.

摘要

盆腔癌是全球最常被诊断出的癌症之一。对患者的治疗需要多学科方法,其中常常包括放射治疗。胃肠道(GI)辐射诱发的毒性是一种主要并发症,由盆腔原发性肿瘤的放射治疗导致的非癌组织中出现的从轻度到非常严重的短期或长期问题,实际上被称为盆腔放射病。盆腔放射病的发病率会根据放射技术、随访时间、评估方法、癌症类型和分期以及其他几个变量而变化。值得注意的是,即使采用最新的放射技术,即调强放射治疗,辐射诱发的胃肠道副作用的发生率总体上有所降低,但仍然不可忽视。此外,辐射诱发的胃肠道副作用甚至可能在几十年后出现;因此,患者预期寿命的提高将不可避免地增加发生辐射诱发并发症的风险。一旦发生,盆腔放射病的管理可能具有挑战性。因此,预防辐射诱发的毒性是避免这些患者生活质量急剧下降的合理方法。在本手稿中,我们对预防盆腔放射病领域的最佳现有证据进行了更新且实用的综述。

相似文献

1
Prevention of pelvic radiation disease.盆腔放射性疾病的预防
World J Gastrointest Pharmacol Ther. 2015 Feb 6;6(1):1-9. doi: 10.4292/wjgpt.v6.i1.1.
2
Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review.前列腺癌放射治疗后的盆腔并发症及其处理:国际协作叙事性综述。
Eur Urol. 2019 Mar;75(3):464-476. doi: 10.1016/j.eururo.2018.12.003. Epub 2018 Dec 17.
3
Pelvic radiation disease: Updates on treatment options.盆腔放射性疾病:治疗选择的最新进展
World J Clin Oncol. 2015 Dec 10;6(6):272-80. doi: 10.5306/wjco.v6.i6.272.
4
Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapy.用于降低接受根治性盆腔放疗的成人胃肠道毒性的营养干预措施。
Cochrane Database Syst Rev. 2013 Nov 26;2013(11):CD009896. doi: 10.1002/14651858.CD009896.pub2.
5
Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate dose.调强放疗可降低盆腔中等剂量放疗时的胃肠道毒性。
PLoS One. 2017 Aug 28;12(8):e0183339. doi: 10.1371/journal.pone.0183339. eCollection 2017.
6
Gastrointestinal Toxicity of Pelvic Radiotherapy: Are We Letting Women Down?盆腔放射治疗的胃肠道毒性:我们是否让女性失望了?
Clin Oncol (R Coll Radiol). 2021 Sep;33(9):591-601. doi: 10.1016/j.clon.2021.04.009. Epub 2021 May 10.
7
Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.关于:罗森塔尔·迪、格拉茨坦·埃。《我们有了一种治疗方法,但疾病是什么?》,《肿瘤学家》1996年;第1期。
Oncologist. 1997;2(1):59-61.
8
Chronic genitourinary and gastrointestinal toxicity of prostate cancer patients undergoing pelvic radiotherapy with intensity-modulated versus 4-field technique.采用调强放疗技术与四野放疗技术对前列腺癌患者进行盆腔放疗后的慢性泌尿生殖系统和胃肠道毒性反应
Am J Clin Oncol. 2007 Jun;30(3):215-9. doi: 10.1097/01.coc.0000256705.93441.a0.
9
Sucralfate versus mesalazine versus hydrocortisone in the prevention of acute radiation proctitis during conformal radiotherapy for prostate carcinoma. A randomized study.硫酸铝与美沙拉嗪及氢化可的松在前列腺癌适形放疗期间预防急性放射性直肠炎中的比较:一项随机研究
Strahlenther Onkol. 2003 Jul;179(7):464-70. doi: 10.1007/s00066-003-1082-4.
10
[Multicenter double-blind clinical trial comparing sucralfate vs placebo in the prevention of diarrhea secondary to pelvic irradiation].[多中心双盲临床试验:比较硫糖铝与安慰剂预防盆腔放疗继发腹泻的效果]
Med Clin (Barc). 1999 Nov 27;113(18):681-4.

引用本文的文献

1
Microencapsulated Sodium Butyrate in the Prevention of Acute Radiotherapy Proctitis: Single-Center Prospective Study.微囊化丁酸钠预防急性放射性直肠炎:单中心前瞻性研究
J Clin Med. 2025 Jul 7;14(13):4783. doi: 10.3390/jcm14134783.
2
IEPA, a novel radiation countermeasure, alleviates acute radiation syndrome in rodents.IEPA是一种新型辐射防护剂,可减轻啮齿动物的急性辐射综合征。
Int J Radiat Biol. 2025;101(1):1-14. doi: 10.1080/09553002.2024.2425312. Epub 2024 Nov 12.
3
Rehabilitation of pelvic floor dysfunction after radiation therapy for a rare gynecological cancer: A case report.罕见妇科癌症放疗后盆底功能障碍的康复:一例报告
Gynecol Oncol Rep. 2024 Oct 20;56:101534. doi: 10.1016/j.gore.2024.101534. eCollection 2024 Dec.
4
Prevention and management of radiotherapy-related toxicities in gynecological malignancies. Position paper on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology).妇科恶性肿瘤放射治疗相关毒性的预防和管理。代表 AIRO(意大利放射治疗和临床肿瘤学协会)的立场文件。
Radiol Med. 2024 Sep;129(9):1329-1351. doi: 10.1007/s11547-024-01844-5. Epub 2024 Aug 28.
5
Improvement of treatment plan quality with modified fixed field volumetric modulated arc therapy in cervical cancer.改良固定野容积旋转调强放疗在宫颈癌治疗计划中的质量改进。
J Appl Clin Med Phys. 2024 Oct;25(10):e14479. doi: 10.1002/acm2.14479. Epub 2024 Jul 20.
6
Variations and effects of bladder and rectal volume following uniform preparation procedure in cervical cancer: Five fractions of 6 Gy.宫颈癌统一准备程序后膀胱和直肠体积的变化及影响:6 Gy,分5次照射。
J Contemp Brachytherapy. 2023 Apr;15(2):123-129. doi: 10.5114/jcb.2023.126863. Epub 2023 Apr 28.
7
Exploiting dietary fibre and the gut microbiota in pelvic radiotherapy patients.利用膳食纤维和肠道微生物群改善盆腔放疗患者的状况。
Br J Cancer. 2022 Dec;127(12):2087-2098. doi: 10.1038/s41416-022-01980-7. Epub 2022 Sep 29.
8
Evaluation of mesalazine polymeric conjugate in the treatment of actinic proctitis in rats.评价美沙拉嗪聚合物偶联物在治疗大鼠光化性直肠炎中的作用。
Acta Cir Bras. 2021 Oct 8;36(8):e360805. doi: 10.1590/ACB360805. eCollection 2021.
9
Update on the management of the gastrointestinal effects of radiation.放射治疗胃肠道反应管理的最新进展
World J Gastrointest Oncol. 2021 May 15;13(5):400-408. doi: 10.4251/wjgo.v13.i5.400.
10
Radiotherapy side effects: integrating a survivorship clinical lens to better serve patients.放疗副作用:融入生存临床视角,更好地为患者服务。
Curr Oncol. 2020 Apr;27(2):107-112. doi: 10.3747/co.27.6233. Epub 2020 May 1.

本文引用的文献

1
Systematic review of agents for the management of gastrointestinal mucositis in cancer patients.系统评价癌症患者胃肠道黏膜炎管理中的药物。
Support Care Cancer. 2013 Jan;21(1):313-26. doi: 10.1007/s00520-012-1644-z. Epub 2012 Nov 10.
2
Management of intestinal complications in patients with pelvic radiation disease.盆腔放射性疾病患者的肠道并发症处理。
Clin Gastroenterol Hepatol. 2012 Dec;10(12):1326-1334.e4. doi: 10.1016/j.cgh.2012.07.017. Epub 2012 Jul 31.
3
Randomised clinical trial: preventive treatment with topical rectal beclomethasone dipropionate reduces post-radiation risk of bleeding in patients irradiated for prostate cancer.随机临床试验:预防性直肠使用倍氯米松二丙酸盐治疗可降低前列腺癌放疗患者放疗后出血风险。
Aliment Pharmacol Ther. 2011 Sep;34(6):628-37. doi: 10.1111/j.1365-2036.2011.04780.x. Epub 2011 Jul 25.
4
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
5
A review of the clinical evidence for intensity-modulated radiotherapy.调强放疗的临床证据回顾。
Clin Oncol (R Coll Radiol). 2010 Oct;22(8):643-57. doi: 10.1016/j.clon.2010.06.013. Epub 2010 Jul 31.
6
Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvis.随机 II 期探索性研究预防性氨磷汀在接受盆腔根治性放疗的癌症患者中的应用。
J Exp Clin Cancer Res. 2010 Jun 10;29(1):68. doi: 10.1186/1756-9966-29-68.
7
Predicting late effects of pelvic radiotherapy: is there a better approach?预测盆腔放疗的晚期效应:是否有更好的方法?
Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1163-70. doi: 10.1016/j.ijrobp.2009.09.011. Epub 2010 Mar 16.
8
An oral history of MASCC, its origin and development from MASCC's beginnings to 2009.MASCC 口述史,记录了 MASCC 从成立到 2009 年的起源和发展。
Support Care Cancer. 2010 Jun;18(6):775-84. doi: 10.1007/s00520-010-0830-0. Epub 2010 Mar 10.
9
Defining pelvic-radiation disease for the survivorship era.为癌症幸存者时代定义盆腔放射病
Lancet Oncol. 2010 Apr;11(4):310-2. doi: 10.1016/S1470-2045(10)70026-7. Epub 2010 Feb 8.
10
Effect of a prostaglandin--given rectally for prevention of radiation-induced acute proctitis--on late rectal toxicity. Results of a phase III randomized, placebo-controlled, double-blind study.直肠给予前列腺素预防放射性直肠炎对晚期直肠毒性的影响。一项III期随机、安慰剂对照、双盲研究的结果。
Strahlenther Onkol. 2009 Sep;185(9):596-602. doi: 10.1007/s00066-009-1978-8. Epub 2009 Sep 12.